Overview

Nobori Dual Antiplatelet Therapy as Appropriate Duration

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
NIPPON trial is a prospective, randomized, trial comparing 6 and 18 months Dual Antiplatelet Therapy (DAPT) following Nobori stent deployment.
Phase:
Phase 4
Details
Lead Sponsor:
Associations for Establishment of Evidence in Interventions
Treatments:
Aspirin